At a glance
ClinicalIndex Comparison RecordPhase 2Completed· 116 enrolled
Drug / intervention
Vitamin D3 +1 moredrug
Likely dose
Vitamin D3 4000IUfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Phase 2 Study Vitamin D3 Effects on Musculoskeletal Symptoms With Use of Aromatase Inhibitors
In Brief
A Phase 2 clinical trial evaluating Vitamin D3 for Muscle Pain and Joint Pain. Completed, enrolled 116 participants across 1 site.
Detailed Summary
The Purpose of this study is to determine whether vitamin D3 supplements will decrease the muscle and bone pain that are reported by women who take Aromatase Inhibitors.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsMuscle Pain, Joint Pain
CountriesUnited States
CollaboratorsUniversity of Minnesota, University of Southern California
Timeline
Phase 2CompletedFinished
201220132014201520162017201820192020202120222023202420252026
First PostedJan 2012
Enrollment StartMar 2012
Primary CompletionOct 2014
Study CompletionMar 2015
TodayJul 2026
First PostedJan 12, 2012
Enrollment StartMar 1, 2012
Primary CompletionOct 1, 2014
Study CompletionMar 1, 2015
TodayJul 2, 2026
Enrollment to primary: 2.6 yearsPosted 14.5 years ago
Interventions
Vitamin D3drug
Cholecalciferol capsule, 4000IU, daily for 6 months
Vitamin D3drug
cholecalciferol capsule, 600 IU, daily for 6 months